Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTA Plus Cisplatin Versus Cisplatin in Malignant Pleural Mesothelioma
NCT00005636Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 1999
- Primary completion
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemetrexed in malignant pleural mesothelioma (MPM), sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 1999; status: completed.
02
Drugs
pemetrexed
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00005636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005636.